Pharmacological Treatment for the Management of COVID 19: A Narrative Review
- PMID: 34508415
- PMCID: PMC8369552
- DOI: 10.31729/jnma.5920
Pharmacological Treatment for the Management of COVID 19: A Narrative Review
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is alarming worldwide incurring tremendous loss of life and possession. Individuals are facing a terrible pandemic condition in the absence of appropriate medicines and vaccines to combat SARS-CoV-2 infection. This review aimed to provide details on potential treatment steps that can be taken in the current pandemic-fighting situation in Nepal. A massive review was performed including 60 articles from the relevant field. Preliminary results on the efficacy of some existing anti-viral agents were found, however, promising data on effective treatment regimen for COVID 19 are yet to be obtained. This review examines various drugs and their mechanism of actions which are currently used in clinical trials or may be used to treat COVID-19 in the near future.
Conflict of interest statement
References
-
- World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 [Internet] Geneva, Switzerland: 2020. Mar 11, https://www.who.int/director-general/speeches/detail/who-director-genera... Available from:
-
- Worldometer. COVID-19 coronavirus pandemic [Internet] 2021. May 19, https://www.worldometers.info/coronavirus/?zarsrc=130 Available from:
-
- Government of Nepal. Ministry of Health and Population. COVID-19 Response Web Portal [Internet] Kathmandu, Nepal: 2021. May 19, https://covid19.mohp.gov.np Available from:
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous